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Simple Summary: The present review summarizes the generated hypothesis and critical role of
quercetin in cardiovascular and neuroprotective diseases reported over the last decade. In this
review, 335 research articles were referred from the popular scientific database (e.g., Scopus and
Web of Science) to elaborate on the importance of quercetin in addressing human ailments and the
health-protective role imparted. Being a valuable bioactive compound within the circular economy
context, the source for obtaining quercetin has been extended for food industrial wastes/byproducts
(mainly of fresh produce). Further, the establishment of the molecular mechanism, antioxidant
potential, oxidative stress, metabolic process, myocardial damage, anti neurogenerative potential,
enzymatic expression, and ROS inhibition renders quercetin an ideal phytochemical that can provide
protective benefits against cardiac and neurodegenerative diseases.
Abstract: Quercetin, a bioactive secondary metabolite, holds incredible importance in terms of
bioactivities, which has been proved by in vivo and in vitro studies. The treatment of cardiovascular
and neurological diseases by quercetin has been extensively investigated over the past decade.
Quercetin is present naturally in appreciable amounts in fresh produce (fruits and vegetables).
However, today, corresponding to the growing population and global demand for fresh fruits
and vegetables, a paradigm shift and focus is laid towards exploring industrial food wastes and/or
byproducts as a new resource to obtain bioactive compounds such as quercetin. Based on the available
research reports over the last decade, quercetin has been suggested as a reliable therapeutic candidate
for either treating or alleviating health issues, mainly those of cardiovascular and neurological
diseases. In the present review, we have summarized some of the critical findings and hypotheses of
quercetin from the available databases foreseeing its future use as a potential therapeutic agent to
treat cardiovascular and neurological diseases. It is anticipated that this review will be a potential
reference material for future research activities to be undertaken on quercetin obtained from fresh
produce as well as their respective processing wastes/byproducts that rely on the circular concept.
Keywords: quercetin; secondary metabolite; cardioprotective and neuroprotective agent; fruits and
vegetable wastes; by-products; circular economy
1. Introduction
Quercetin is a carbohydrate-free flavonoid, a secondary metabolite found in flora,
including fresh produce (fruits and vegetables), some of which include red onion, apples,
and berries. These compounds have been studied to evaluate the biological activities of
flavonoids [1]. The overview depicting the theme of this review is given in Figure 1 [2–4].
These properties of quercetin have been attributed primarily to their antioxidant capacity
and free radical scavenging ability. Quercetin intake has been found to affect mitochondrial
biogenesis, energy production, electron transport chain performance, ROS production
modification, and mitochondrial defect modification [5,6]. The antioxidant potential and
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free radical scavenging ability have played a major role in explaining quercetin’s neuropro-
tective effects with the exceptional property of passing the blood–brain barrier. Thus, based
on the thorough literature analysis (past decade) from the available databases (in Scopus
and Web of Sciences), this review is being designed for cardioprotective and neuroprotec-
tive effects. However, to the authors’ knowledge, there have been very limited reviews



























Figure 1. Quercetin: Sources, structure and uses.
On another note, currently, the food industry’s post-processing wastes and byproducts
have gained much importance in the present-day circular Bioeconomy concept scenario.
In the circular economy, an approach contrary to the traditional linear economy (TLE) is
adopted; in TLE, products after use are thrown away. These products are manufactured by
the extraction and processing of raw materials, usually non-renewable resources. However,
the Bioeconomy (BE) includes the production of renewable biological resources and the
transformation of these resources and waste streams into added-value products. The meet-
ing point of these three economic concepts as an intersection is the Circular Bioeconomy
Concept (CBEC), where the raw material, e.g., biomass, is utilized as renewable resources
as it includes byproducts, residues, and waste. This approach retains raw material in a
closed material loop and hence enhances productivity. In addition, raw material by the
process of recycling can be converted into prototypes of different uses. Fruits and vegetable
wastes/byproducts, being a cheap source of raw materials, have been recommended to
be exploited for the isolation of bioactive and other value-added compounds. Besides,
these wastes and byproducts also help towards minimizing environmental pollution-based
issues [7–10]. Hence, there is ample scope to obtain bioactive compounds such as quercetin
from fruit and vegetable-based industrial wastes and byproducts. With this background,
this review aims to provide guidance and reference for future cardioprotective and neuro-
protective aspects of quercetin. Besides, additional focus is also laid towards identifying
the potentiality of exploiting food industrial wastes and byproducts to obtain quercetin
2. Discussion
2.1. Quercetin as a Cardioprotective Agent
Based on pharmacological evidence, quercetin obtained from fruits and vegetables
has the tremendous ability to act as a cardioprotective agent. The muscular function is
greatly influenced by its antioxidative and antiplatelet properties. These properties prompt
actions such as anti-smooth muscle cell proliferation and migration, which in turn improves
cardiac cell mitochondrial function and inhibits nuclear factor-kappa light chain-enhancer
of activated B cells (NF-κB), as stated by Ay et al. [11]. Sengul et al. [3] reported protective
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effects of quercetin in rats and demonstrated that the dosage of 50 mg/kg and 100 mg/kg of
quercetin have significant protective effects on the 5-FU-induced cardiotoxicity in rats after
14 days of administration. Quercetin can reduce cardiovascular disease linked to brain-
derived neurotrophic factor (BDNF); in this aspect, Wang et al. [2] stated that quercetin
exerted significant antidepressant and cardioprotective effects in mice. A diet of high
fat is linked to perturbations in the metabolism of fatty acids and contributes to cardiac
diseases such as cardiometabolic syndrome and cardiac damage, which can be alleviated
by quercetin by restoring myocardial microcirculation as studied by Yu et al. [12]. The
beneficial effects of quercetin help in decreasing plasma triglycerides and intramyocardial
fat deposition [12]. Rolnik et al. [13] investigated quercetin derivatives for the development
of new anti-platelet strategies and management of current therapies in cardiovascular
diseases linked to hyper-activation of platelets. Further, Elbarbry et al. [14] have elaborated
the role of quercetin by studying its role in lowering blood pressure. The effect of quercetin
in spontaneously hypertensive rats (SHR) was studied by administrating different con-
centrations of quercetin. The enzymatic activity of rats suggested that medium and high
doses of quercetin resisted high blood pressure. They hypothesized that quercetin has
anti-hypertensive and provided a novel mechanism for its underlying cardioprotective
properties [14]. The protective effects of quercetin against isoproterenol-induced myocar-
dial ischemia and verification of the cellular mechanisms based on the L-type Ca2+ channel
(LTCC), Ca2+ transients, and myocardial contractility was reported by Liang et al. [15].
In their animal model, they hypothesized that quercetin gives a cardioprotective effect
by inhibiting Ca2+ influx and contractility in experimental animals. Besides, the ‘Zi Shen
Huo Luo Formula’ (ZSHLF), a traditional Chinese-medicine-(TCM)-based herbal formula,
consists of many drug material components. Quercetin is among these components that
tend to exhibit cardioprotective effects, as studied by Song et al. [16]. They supported their
results by establishing a mechanism by carrying in vitro studies using rats. However, they
also insisted that in ZSHLF, major bioactive components or metabolites are responsible
for the effects and the implications of these findings in patients and further research is
needed. The inhibition of myocardial damage due to recurring chest pain is the main issue
in heart disease. The results indicated that the cardioprotective effect of QPC highlights
the importance of anti-arrhythmogenic during ischemic heart disease. These results can
be a milestone for a new direction for the treatment of myocardial infarction. Quercetin,
along with its derivatives, such as rhamnetin, rutin, and hyperoside, has been reported
to impart a positive influence on the cardiovascular system [17]. Further, Ferenczyova
et al. studied the effects of quercetin and its metabolites on cardiac injury through their
antioxidant, anti-inflammatory, and molecular pathways-modulating properties. However,
it was revealed that due to a low number of clinical trials focused on cardiac effects of
quercetin and its derivatives, clinical data were inconclusive [18]. In their other study,
cardiovascular benefits of quercetin in diabetic rats of different ages. It was reported
that quercetin might be advantageous for vascular function in diabetes type 2; however,
increasing age and/or progression of diabetes may confound its vasculoprotective effects.
Though, quercetin was not so effective in preventing myocardial ischemia-reperfusion
(I/R) injury in type 2 diabetes and older age [19]. Wang et al. [20], after establishing the
structure of quercetin by spectroscopic data, studied its cardioprotective properties. The
cardioprotective effects of quercetin against oxidative stress of H9c2 cells induced by H2O2
showed quercetin derivatives exhibited protective effects against H9c2 cells injury induced
by H2O2 The cardioprotective effects of quercetin-containing drugs, corvitin and lipoflavon,
were reported first time by Stechyshyn and Pavliuk [21]. Quercetin can relieve endoplasmic
reticulum dysfunction in Pak2-CKO hearts. The findings of using quercetin uncovered a
new cardioprotective mechanism and therapeutic strategy for encouraging options for treat-
ing cardiac disease and heart failure [22]. The cardioprotective index (CI) has been studied
in diabetic rats after treatment with quercetin for 28 days. Ogar et al. [23] attributed the
enhanced CI to the use of quercetin. The cardioprotective effects of quercetin, along with
a dietary supplement, alpha-linolenic acid, have been described by Burak et al. [24].The
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quercetin derivative was used to study cardiac dysfunction, scavenging free radicals, and
reduced lipid peroxidation, as reported by Shu et al. [25] and attributed cardioprotective
effects of quercetin derivative to partially counteracted PI3K/Akt inhibitor LY294002. Wang
et al. [26] isolated glycosidic derivative quercetin and studied their cardioprotective effects
against H2O2-induced apoptosis in H9c2 cells. At micromolar concentrations, the quercetin
glycosides exhibited stronger activity than the acylated quercetin glycosides.
Chakraborty et al. [27] studied quercetin in combination with curcumin as a bio en-
hancer for ischemia–reperfusion injury (IRI) induced myocardial toxicity in rats. After
30 days of treatment, it was observed that a combination of these two phytoconstituents
exhibited intense protection of IRI-induced myocardial toxicity and was further supported
by pharmacodynamic interaction [27]. The cardioprotective effects of quercetin in animals
exposed to intermittent hypobaric hypoxia (IHH) were studied by Chis et al. [28]. The
oxidative/nitrosative stress increases by hypobaric hypoxia in heart tissue and quercetin
act as a cardioprotective agent, which reduces the oxidative cardiac dysfunction induced by
oxidative/nitrosative stress [28]. Quercetin administration in a group of rats through
myocardial energy metabolism restoration gives a prophylactic effect in response to
adriamycin-induced toxic effects [29]. LC-MS/MS analysis was performed for the de-
tection and determination of the bioactive constituents, including quercetin, in methanol
extract of Alternanthera philoxeroides (Mart.) Griseb. It was revealed by in vitro cell evalu-
ation studies that methanol extracts significantly stopped cardiomyocyte apoptosis [30].
The cardioprotective effects of quercetin against the damage induced by a high-cholesterol
(HC) diet in hyperglycemic rats was studied, which was attributed to intracellular an-
tioxidant mechanisms and bioenergetics [31]. These researchers observed that quercetin
reduced HC-induced changes in the lipid profile and glycemia in experimental rats. The
systolic cardiac function was enhanced in mice administrated with quercetin. The rapid
metabolization of quercetin to tamarixetin was maintained at a higher concentration for
enhancement of systolic cardiac function, as reported by Hayamizu et al. [32]. Quercetin
can exert cardiotonic action via digitalis-like enhancement of Ca2+ transients by itself and
its metabolite, tamarixetin.
The effects of quercetin on cardiac parameters and ischaemia–reperfusion (I/R) injury,
the Langendroff method was used on male Wistar rats by Garjani et al. [33]. The reported
results indicated that at lower quercetin concentrations, a protective effect against I/R in-
juries in isolated rat hearts was observed. The conjugation of quercetin with the anticancer
drug doxorubicin was evaluated by Alrushaid et al. [34] to understand its cardioprotec-
tive effects and the mechanism involved. The cardioprotective mechanism of conjugated
doxorubicin–quercetin involved scavenging of ROS and CYP1B1 inhibition. The cardio-
protective roles of quercetin against I/R injury and the underlying mechanism based on
molecular signaling were reported by Li et al. [35]. The model based on oxygen-glucose
deprivation/reoxygenation (OGD/R) of I/R was reported in myocardial H9c2 cells in the
absence or presence of quercetin. Their results supported the fact that a dual character
of quercetin is involved in the process of myocardial I/R. The extensive data reported by
Ballmann et al. [36] revealed that quercetin improves various metabolic processes such as
mitochondrial biogenesis and antioxidant enzymatic action. The availability of quercetin
facilitates dystrophin-associated glycoprotein complex (DGC) assembly and decreases in-
flammation in dystrophic hearts. Along with other polyphenols, quercetin was studied for
cardioprotective potential in different fractions of Syzygium cumini L. seeds [37]. The control
of angiotensin-converting enzyme (ACE), HMG-CoA reductase, LDL oxidation, and ter-
tiary butyl hydrogen peroxide (TBHP) was exhibited by Syzygium cumini L. seed fractions
rich in quercetin content. The investigation on streptozotocin-nicotinamide-induced adult
male diabetic rats administrated quercetin with different concentrations orally for 28 days.
A decrease in glucose levels in addition to the reduction in other necessary parameters,
including cardiac injury marker levels, were found. They hypothesized that quercetin
could be used to improve myocardial damage due to oxidative stress, inflammation, and
apoptosis in diabetes [38]. In preventive therapy for cardiac disease, cardioprotection
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represents one of the most important and realistic aspects, and quercetin helps to a great
extent in providing cardioprotection. Kumar et al. [39] explored the cardioprotective ac-
tivity of quercetin and related mechanisms. Wister rats were given quercetin orally for
14 days. It was observed that quercetin pre-treatment exhibited protective effects on the
heart. Isoproterenol-induced oxidative stress, inflammation, protection of heart archi-
tecture, and down-regulation of the expression of calpain were significantly reduced by
quercetin treatment. Thereby concluded that quercetin has cardio-protective potential and
established its mechanism of action against isoproterenol-induced myocardial infarction
(MI) in experimental rats. The inhibition of chronic-unpredictable-stress-(CUS)-induced
left ventricular dysfunction (LVD) in rats by quercetin in an animal model was studied by
Bin-Jaliah [40]. It was hypothesized that quercetin tends to prevent myocardial infarction
(MI) induction by CUS. The rats were treated with a constant dosage of quercetin for
3 weeks. The measurable parameters, such as blood pressure and electrocardiogram (ECG),
along with histological study, were taken into consideration prior to quercetin treatment.
It was observed that quercetin treatment lowered blood pressure and substantially pre-
vented MI attributed to the blocked elevation of the ST-segment on the ECG. Furthermore,
the significant inhibition of expression of Bax RNA messages and blocked CUS-induced
TNF-α and IL-6 upregulation led to the efficacy of quercetin treatment. Thus, a possible
therapeutic role for quercetin in CUS-induced cardiac dysfunction was established by
Bin-Jaliah [40]. Quercetin was studied for its effect on myocardial ischemia in patients
with stable coronary heart disease (CHD) by Chekalina et al. [41]. With the intake of
constant dosage of quercetin for 45 days, the deceleration time (DT) value and premature
ventricular contraction (PVC) number dropped significantly by the usage of quercetin.
Thus, the cardioprotective properties of quercetin in conditions of CHD were recognized.
The generation and excessive production of reactive oxygen species (ROS) lead to oxidative
stress in the body and are considered major reasons for cardiovascular diseases (CVDs).
The production of reactive radicals is one of the major management strategies for CVDs
along with other factors and can be controlled by quercetin, as reported by Ramachandran
et al. [42]. Quercetin treatment for isoproterenol-induced toxicity in H9c2 cardiomyoblast
cells was studied. The treatment with quercetin prompted a protective effect by augment-
ing the antioxidant prominence of the cells [42]. Thus, based on animal models, oxidative
stress, metabolic process, myocardial damage, enzymatic expression, ROS inhibition, and
cell line studies, an extensive approach has been opted to establish the importance of
quercetin as a cardioprotective agent. Some of the selected works reported on the role of
quercetin as a cardioprotective agent are given in Table 1.
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Table 1. Some recent reports on the role of quercetin as a cardioprotective agent.
Role Mode Reference
Translocation of NFκB, and expression of TGF-β1, CTGF,
and BNP In vivo [43]
Cardioprotective effects restoring plasma thyroid
hormone levels and attenuating oxidative stress in
the heart
In vivo [44]
Inhibition of JNK and p38 mitogen-activated protein
kinase signaling pathways In vivo [45]
Inhibits angiotensin-converting enzyme activity, improves
vascular relaxation, and decreases oxidative stress and
gene expression
In vitro, in vivo [46]
Post-ischemic recovery of left ventricular developed
pressure, as well as recovery of markers of contraction
and relaxation, respectively
In vivo [47]
Cardioprotective In vivo [48]
Myocardial infarction
Release of creatine kinase-MB (CK-MB), lactate
dehydrogenase (LDH) level in coronary effluent and
reduced myocardial infarct size
In vivo [49]
Biology 2021, 10, 586 7 of 34
Table 1. Cont.
Role Mode Reference
Myocardial ischemia-reperfusion injury via suppressing
the NF-κB pathway In vivo and in vitro [50]
Protein disulfide isomerase (PDI) inhibition for
cardiovascular benefits In vitro [51]
Protects cardiomyocytes against oxidative toxicity and the
regulation of stress-sensitive protein kinase cascades and
transcription factors.
In vitro [52]
Lowers ABP in patients with hypertension In vivo [53]
Cardioprotective control In vitro [54]
Endothelial function and reducing inflammation, vascular
function, and cardiometabolic health In vivo [55,56]
Improve cyclosporine-induced cardiotoxicity, as it has
antioxidant and anti-inflammatory enzyme activities In vivo [57]
Atherogenic and cardioprotective indices In vivo [58]
Reduction in cardiac and renal markers of oxidative stress In vivo [59]
Antichronic doxorubicin cardiotoxicity via antioxidant
and anti-inflammatory properties In vivo [60]
Antioxidative cardiotoxicity and dyslipidemia In vivo [61]
Cardiac weight index and myocardial enzyme activity
Antioxidative stress, inhibition of the
renin–angiotensin–aldosterone system
In vivo [62]
Ischemia/reperfusion injury in cardiomyocytes In vitro [63]
Anti-doxorubicin-induced cardiomyopathy in H9c2 cell;
myocardial ischemia/reperfusion injury in rats through
the PI3K/Akt pathway
In vitro [64,65]
Induce activation of AMPK and eNOS in human aortic
endothelial cells In vivo [66]
Cardioprotective effect of GSK-3b inhibitors In vivo [67]
Reduction of the serum CK-MB, LDH, and SGPT
level enzymes In vivo [68]
Protects rat hearts from oxidative stress by its
antioxidant potential In vivo [69]
Decrease in doxorubicin-induced cytotoxicity and
promoting the cell repair system in cardiomyocyte
H9C2 cells
In vitro [70]
2.2. Quercetin as a Neuroprotective Agent
A unique four-step strategy comprising of ‘Global profiling’, ‘Chemical structural clas-
sification’, ‘Intra-group screening’, and ‘Component-knockout optimization’ was adopted
to screen and optimize the functional compound combination (FCC) from traditional
Chinese medicine (TCM). The holistic neuroprotective effects of the FCC consisting of
quercetin indicated antioxidative and anti-inflammatory responses in PC12 cells to save
them from oxidative stress, as reported by Wang et al. [71]. The group hypothesized that
the reported strategy could offer an alternative to discover phytochemicals of biological
importance, such as quercetin used in traditional medicines. The hexane extract of Spondias
mombin L. (Anacardiaceae) ‘Cajazeira’ containing quercetin has shown a neuroprotective
effect via anxiolytic and antioxidant activities in zebrafish [72]. The study on elaboration
mechanism explaining the effects of extract containing quercetin on neuroprotective bene-
fits was established. Eclipta alba L. ‘Bhringra’ hydroalcoholic extract containing quercetin
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along with other phytoconstituents was reported by Bhatia et al. [73]. It was further
stated that cellular antioxidant and enzymatic expression showed improvement by using
Eclipta alba L. extract, therefore projecting this as a potential plant for the generation of
the therapeutically neuroprotective agent. The first-time isolation and identification of
quercetin glycosidic derivative from Hibiscus rosasinensis L. was reported by Shen et al. [74].
This derivative was suggested for the prevention of Alzheimer’s disease. The effect of
quercetin-loaded microcapsules was analyzed for neuroprotective properties in Wistar
adult rats by studying nitrergic neurons reducing oxidative damage [75]. In a comparative
study by Jalili-Baleh et al. [76], quercetin was chosen as the standard for a neuroprotective
activity for chromone–lipoic acid hybrids. The use of quercetin can protect retinal cells
from deterioration and had not dilapidated their function [77]. The researchers related the
protective effect of quercetin and other phytoconstituents to higher expression of certain
proteins (photoreceptor-specific proteins), photoreceptors (rhodopsin and cone opsins),
and at the same time to reduced expression of particular inflammatory markers.
The dietary intake of quercetin was recently studied in an animal model (mice) by
Zhang et al. [78] to establish its role in reducing depression, a true neurological problem.
These findings supported astrocyte reactivation in the regulation of quercetin neuropro-
tection and hypothesized that a quercetin-rich diet intake in fruits, vegetables, and food
additives would relieve the stress. The effect of injected quercetin at different intervals
in neonatal mice with hypoxic–ischemic brain injury was reported by Le et al. [79] to
study its neurological functions. The administrated quercetin protected microglial cells
(BV2 cells) from oxygen-glucose deprivation (OGD) induced damage; further microglial
oxidative stress-related molecules were intercepted. The hepato-neuroprotective effect of
extracts of Barnebydendron riedelii Tul. was attributed to its quercetin content by Baraka
et al. [80]. It was stated that glycosidic quercetin, through its modulatory effects on NF-
κB/IL-6 and Nrf2/HO-1 signaling pathways, is enabled to exhibit a protective effect. A
quercetin-integrated Cyclodextrin complex was studied for its neuroprotective behavior in
nose-to-brain Que’s delivery systems [81]. The obtained results were warned further ex
vivo and in vivo studies for delivery of specific targeted delivery. Quercetin and quercetin
4′-O-glucoside were biologically evaluated for cerebral ischemia-reperfusion in mice. The
quercetin extractives from different extracts showed different neuroprotective effects. It
was suggested that further evaluation for neurotoxic effects and appropriate neuroprotec-
tive mechanisms should be continued to explore [82]. The neurotoxic damage induced
by Bisphenol-A (BPA) in zebrafish (Danio rerio) and the effect of quercetin supplement
treatment was carried out by Sahoo et al. [83]. The neurobehavioral response, oxidative
stress, and neuromorphological changes were observed by the use of quercetin and it was
considered as an effective agent to intervene in the induced neurotoxicity in Zebrafish by
BPA. The delivery of drugs while crossing the blood–brain barrier (BBB) to a selected site
to treat Parkinson’s disease (PD) is a challenging issue. Thus, modification in treatment
is needed; in this aspect, nanoparticles were used to carry the drugs to the selected tar-
get. Quercetin is an anti-Parkinson disease agent, and recently Liu et al. [84] used gold
nanoparticles loaded with quercetin to study the enhancement in BBB permeability of
quercetin via the photothermal effect. The results revealed that by this treatment, quercetin
was accumulated in the brain and it was further hypothesized that nanoparticles could
have the potential for neuroprotective drug delivery and treatment for PD. In another
study, quercetin nanoparticles were studied for their better availability. A constant dose of
quercetin nanoparticles was administrated to animals along with AlCl3. Based on micro-
scopic results, nanoparticles showed neurogenerative changes and improvement of tyrosine
hydroxylase (TH), and this study was the first study revealing the therapeutic effects of
quercetin nanoparticles for Alzheimer’s disease (AD) model and further investigation was
warned by Rifaai et al. [85]. Neuroprotection against cerebral ischemia/reperfusion injury
in rats was studied by Wang et al. [86] using quercetin oral pretreatment. Neuroprotec-
tive parameters such as brain infarction, blood–brain barrier disruption, oxidative stress,
TNF-α, and IL-1β mRNA expression, along with apoptotic caspase 3 activity, and with
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neuroprotective, anti-oxidative, anti-inflammatory, and anti-apoptotic effects of quercetin,
were reported. The increase in ERK/Akt phosphorylation and protein phosphatase ac-
tivities and at the same time inhibition of ERK or Akt were studied to report the cause
of apoptotic cell death and cytotoxicity in hippocampal slice cultures and neuron/glia
cultures. In conclusion, it was hypothesized that the role of quercetin was prominent
in improving the protein tyrosine and serine/threonine phosphatase activity, followed
by reduction of ERK and Akt phosphorylation, thereby addressing the important role
of quercetin in understanding its neuroprotective behavior [86]. The administration of
quercetin supplementation leads to an increase in the bioavailability of NO in the jejunum
in euglycemic diabetic rats. This treatment reduces the effects of diabetes on nNOS-IR
neurons and VIP-IR varicosities in the myenteric plexus of experimental diabetic rats, as
reported by Martins-Perles et al. [87]. The presence of quercetin in Camellia nitidissima Chi,
‘Tea for Longevity’ a well-known plant consumed as both medicine and food in China, was
studied for its neuroprotective effect by An et al. [88]. Based on two used terms, ‘synergisti-
cally boosting endogenous antioxidant defences’ and ‘neurotrophic signalling pathway’ by
An et al. [88], this plant has been cited as an important source for phytonutrients, including
quercetin for edible foods and beverages. Soxhlet extraction to yield quercetin along with
other phytoconstituents from Pinus roxburghii Sarg. by Sharma et al. [89] for in vivo and
in vitro studies was carried out to evaluate neuroprotective activity in rats. It was reported
by Karaman et al. for the first time that quercetin obtained from mushrooms (Coprinus
comatus (O.F.Mull.) Pers.) exhibited neuroprotective activity [90]. This plant has been
cultivated in China and can be used as an acetylcholinesterase (AChE) inhibitory agent.
The work on dopaminergic human SH-SY5Y cell lines using quercetin was evaluated for the
neuroprotective role [91]. The impact of rotenone-induced neurotoxicity in SH-SY5Y cell
lines was studied by correlating intracellular reactive oxygen species (ROS) and imbalance
in the mitochondrial membrane potential (MMP). It was established that quercetin gave
cells protection against rotenone; this quercetin was hypothesized as a therapeutic agent
with significant neuroprotective potential. The neuroprotective effect and control of gut
microbiota linked with nerve damage in diabetic rats using quercetin were studied by Xie
et al. [92]. It was suggested that quercetin has a therapeutical potential to reduce diabetic
peripheral neuropathy (DPN) in rats and can be considered as a key component for the
treatment of such neuropathic-related issues. The role of quercetin in treating neurotoxicity
caused by metronidazole by obstructing the proportion of antioxidants in the brain tissue
and inducing nitric oxide synthesis along with apoptosis. Quercetin was found active to
protect against such neural damage by Chaturvedi et al. [93]. Nanoparticles can enhance
the delivery of quercetin, as stated by Pinheiro et al. [94]. The blood–brain barrier was
targeted by such designed nanoparticles. By this approach, the neuron was protected
against amyloid-beta fibrillation; thus a targeted delivery of quercetin was achieved, and a
novel strategy to treat Alzheimer’s disease can be generated. The hydroalcoholic extract
of coffee silverskin containing quercetin along with other polyflavonoids was reported
for its neurodegenerative activity attributed to counteract oxidative stress and maintain
cell viability [95]. The neuroprotective activities in rats using quercetin were determined
by de Mattos et al. [96]. The neuroprotective properties of quercetin for treating autism
in an animal model is being hypothesized as an important therapeutic candidate for ad-
dressing neurological disorders such as autism spectrum disorders (ASDs). Quercetin
with hydroxyl groups on the ortho position can have been reported to provide enhanced
neuroprotection as reported by Lossi et al. [97]. This study contributed towards a new
finding in the translation application of polyphenols, as stated by the researchers. The
spectroscopic analysis was used to characterize lipid nanoparticles encapsulated with
quercetin and used as neuroprotective agents. The results revealed that the nanoparticles
are appropriate for brain applications, particularly for Alzheimer’s disease, due to the inhi-
bition of amyloid-beta aggregation [98]. Quercetin was found as a major constituent in the
methanolic stem extract of Colebrookea oppositifolia Smith. with a potential of cerebroprotec-
tive activity against ischemia–reperfusion-induced brain injury during in vivo studies [99].
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The oral administration of quercetin at constant dosage in mice was studied for the counter
effects of Aflatoxin B1, a mycotoxin in mice. The antioxidant effect of quercetin led to
a preventive role against oxidative stress by supporting antioxidative defense systems
and restraining the lipid peroxidation process [100]. Euonymus alatus (Thunb.) Siebold.
a food plant consumed as traditional medicine in East Asian countries, has been found
rich in quercetin. The extract from the plant was utilized for anti-neurotrophic factors.
The defense in the mouse hippocampus from scopolamine-induced damage through as
brain-derived neurotrophic factor-mediated Nrf2 activation was established by the use of
quercetin by diminishing cognitive decline [101]. The potential toxin in diet responsible for
the pathogenesis of Alzheimer’s disease (AD) is dietary advanced glycation end products
(dAGEs), as stated by Yang et al. [102]. Thus, experimental mice were treated with quercetin
after giving dAGEs for 21 days. The results evaluating different biochemical pathways
suggested that treatment by quercetin supplication has improved cognitive function in
experimental animals. A similar study was carried out by Yang et al. [103] by stating that
extended application of quercetin may be beneficial for high consumers of dAGEs. The
neurotoxicity by the exposure of pesticide fenitrothion has led Ibrahim et al. [104], to carry
out a study in rats for the role of quercetin against the development of such neurological
impairment. The study leads to the hypothesis that quercetin can prove helpful against fen-
itrothion by downregulating apoptosis-related genes and catecholamines. Thus, it can be
exploited as a neuroprotective agent. Shalavadi et al. [105] carried out the neuroprotective
capability of Convolvulus pluricaulis Choisy extracts and their comparison with quercetin
in mice. Diabetic encephalopathy (DE) can be improved by the use of quercetin as estab-
lished by studying the SIRT1/NLRP3 pathway by Vieira-Frez et al. [106]. The crucial link
between the use of quercetin and neuroprotective efficacy in diabetic encephalopathy (DE)
was reported by them in mice. A similar study was reported by Hu et al. [107] wherein
SIRT1/NLRP3 pathway was considered a crucial mechanism for the neuroprotective effect
against DE using quercetin in mice used as a diabetic model animal [107]. The results
presented by Park et al. [108] were able to justify that quercetin can be considered as
an active component for mediating the neuroprotective role by controlling thioredoxin
expression and maintaining the interaction between apoptosis signal-regulating kinase
1 (ASK1) and thioredoxin, an antioxidant. The findings suggest that quercetin mediates
its neuroprotective function by regulation of thioredoxin expression and maintenance of
interaction between ASK1 and thioredoxin. Quercetin in combination with piperine was
studied for neuroprotective effect against rotenone- and iron-supplement-induced PD
in experimental rats. It was found that this combination was quite effective in treating
Parkinson’s disease (PD) in rats [109]. The neuroprotective effects of quercetin in Wistar
rats as subarachnoid hemorrhage (SAH) model animals for its role in visualizing the ef-
fects against cerebral vasospasm was reported by Gül et al. [110]. The biochemical and
histopathological evaluation reported revealed that quercetin has a crucial role in SAH
therapy by stopping vasospasm. The copper-induced neurodegeneracy in injured P19
neuronal cells can be countered by the use of quercetin, as stated by Zubčić et al. [111]. MTT
assay, preventing ROS formation, caspase-3 activation, and chromatin condensation by
using 150 µM quercetin was the basis to prove the neuroprotection offered by it. However,
further detailed pharmacological and toxicological studies to establish its role were warned.
The controlled and sustained release of quercetin at targeted neuron cells was carried out by
loading quercetin poly (D,L-lactide-co-glycolide)-poly(ethylene-glycol)-poly(D,L-lactide-
co-glycolide) (PLGAPEG-PLGA) hydrogel. The results obtained suggested that oxidative
damage and inflammation in the spinal cord were improved along with increase neuron
survival rate and promotion in nerve regeneration and motor function recovery. The
authors suggest that the sustainable approach of quercetin delivery has promising applica-
tions in the clinical treatment of brachial plexus avulsion (BPA) [112]. Based on the study
carried out by Yu et al. [113] the increase in the survival rate of PC12 injured by Aβ25-35,
promotion of cell proliferation, and antagonization of the toxicity of Aβ due to quercetin,
led it to be considered as a strong agent as a drug candidate for the treatment of Alzheimer
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disease. The neurotoxic effects of styrene 7,8-oxide (SO) and its cytotoxicity mechanism
were studied using quercetin as a neuroprotective agent. The presented results were in
agreement that cytotoxicity of SO was mediated by oxidative stress and apoptosis, necrosis,
and necroptosis mechanisms, and at the same time, quercetin delivered the neuroprotec-
tion [114]. Quercetin 3, 7-O-α-L-dirhamnoside, a quercetin derivative, was found actively
in providing a protective effect against induced neurotoxicity [115]. The brain targeting
of quercetin-loaded exosomes enhanced its bioavailability in Alzheimer’s disease (AD)
and further relieved the symptoms of AD via inhibition of biochemical pathways such as
cyclin-dependent kinase 5 (CDK5)-mediated phosphorylation of phosphoprotein Tau and
decrease of the formation of insoluble neurofibrillary tangles (NFTs) [116]. Malik et al. [117]
and Gao et al. [118] exploited extracts Lactuca sativa L. and Lycium ruthenicum Murr. extracts
rich in quercetin content, and proved their neuroprotective potential. Chronic neuroin-
flammation is the leading cause of anxiety issues. Quercetin has been proven to reduce
such inflammation and can be considered as a potential agent for inhibiting anxiety-like
symptoms in neuropsychiatric diseases, as stated by Lee et al. [119]. Nanoquercetin via
endocytic cell proliferation can be slowly released as seen in the model studies and has
shown better action as compared to quercetin, thus can be considered as a new milestone
for providing treatment for Alzheimer’s disease [120]. The Enteric Nervous System (ENS)
is affected by arthritis, and Piovezana Bossolani et al. [121] studied the impact of quercetin
alone and in combination with ibuprofen for 60 days in rats and found that combina-
tion treatment was found to be remarkably effective in treating arthritis, thus ENS [121].
Quercetin derivative was also found to be effective in diabetic rats to control neurological
damage [122]. Quercetin exhibited neuroprotective effects on cell viability, morphology,
and gene expression following corticosterone exposure, as reported by Donoso et al. [123].
It was hypothesized that quercetin defends cortical cells against corticosterone-induced
cytotoxicity and, at the same time, improves cell survival through the Nrf2 pathway and
expression of Fkbp5. Similarly, Nrf2 dependent HO-1 signaling by quercetin derivative was
found a potential agent in addressing Parkinson′s disease management [124]. Quercetin
was found to bind regulatory sites in α7-PAM, leading to a reduction in reactive oxy-
gen species. This allosteric property of quercetin, as reported by Nielsen et al. [125] was
considered as scaffolds for the development of new neuroprotective therapeutic candi-
dates. The calorimetric MTT assay was carried out to investigate the effect of quercetin as
compared with estrogen in its role in Alzheimer’s diseases and was able to establish its
role in neuroprotection [126]. The blueberry extracts rich in quercetin were administrated
in mice at different concentrations. The neuroprotective and antidepressant-like effects
were attributed to the presence of a high concentration of flavonols and pigments such
as quercetin and anthocyanin, respectively [127]. Similarly, Viola cornuta L. and Viola x
wittrockiana Gams edible flower extracts were examined for neuroprotective effect against
paralysis in round worm (Caenorhabditis elegans) by Moliner et al. [128]. They claimed
that quercetin derivative quercetin-3-O-(6-O-rhamnosylglucoside)-7-O-rhamnoside was
responsible for the neuroprotective properties. Pistacia lentiscus L. leaves extract (PL)
containing quercetin and quercetin rhamnoside also exhibited neuroprotective potential
investigated in a mice animal model, as mentioned by Azib et al. [129]. The synergetic
effect of quercetin in combination with sitagliptin has shown neuroprotective potential in
β-amyloid (Aβ)-induced Alzheimer’s disease in male Sprague Dawley rats as reported by
Li et al. [130]. Wu et al. [131] treated brain-injured rats with quercetin and hypothesized
that quercetin could be used as a therapeutic drug to alleviate the injury caused in the
brain by hypoxic ischemia. Quercetin, in its neuroprotective role, was considered to prove
a beneficial moiety in controlling the oxidative-induced apoptotic events during insecticide
chlorpyrifos exposure in rats [132]. It was witnessed that for chlorpyrifos treated rats, a
substantial drop in the protein expression level of Bcl-2 occurred, but at the same time, a
notable increase in the expression levels of Bax, cytochrome c, caspase-8, and caspase-9
was observed in the cerebrum and cerebellum, thus justifying the role of quercetin as a
neuroprotective agent.
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Among the isolated flavonoids from the medicinal herb Achyrocline satureioides Lam
D.C. (Compositae) ‘marcela’ quercetin was found more effective as compared to lute-
olin and isoquercitrin in providing neuroprotection [133]. In hypoxia-induced injury of
pheochromocytoma (PC-12) cells, quercetin was found to be effective by activating AMPK
and Wnt/β- catenin signaling pathways via down-regulation of miR-122 as reported by
Yan et al. [134]. Quercetin was reported to be found in the brain and other organs, including
tumors induced in mice for studying the intake of Ilex paraguariensis A. St.-Hil [135]. They
hypothesized that quercetin and chlorogenic acid present in Ilex paraguariensis A. St.-Hil, if
taken in diet, can reduce lung cancer-related neuroinflammation. Chlorpyrifos, a pesticide,
has been found to alter neuro-histoarchitecture. After treatment with quercetin, a significant
improvement was observed. It was suggested that quercetin prevents chlorpyrifos-induced
neurotoxicity [136]. The quercetin derivatives obtained from apple tree leaves showed a
significant neuroprotective effect at low concentrations of 0.5–1.0 mg/L as compared to
other phytoconstituents [137]. The results presented by Chatterjee et al. [138] revealed the
neuroprotective importance of quercetin in treating dorsal root ganglion (DRG) neurons
exposed to radiation-induced ER stress. The neuroprotective role of quercetin against
oxidative stress-related neurodegenerative ailments in cortical brain tissue cultures from
Wister rats was studied [139]. Further, the effective role of quercetin in neuron survival,
Polyphenol-enriched micronutrient mixture, PMM containing quercetin was also studied
for the neuroprotective potential [140]. The neuro potential of PMM was justified by ex-
plaining the inhibitory activity on CBP/p300 or stimulating activity on the AMP-activated
protein kinase–sirtuin 1 pathway. Achyranthes aspera L. aerial parts were subjected to al-
coholic extraction to examine their cerebroprotective potential [141]. The detailed study
presented explained the suppression of ROS generation nitrite and TNF-α in LPS activated
RAW 264.7 cell lines. Quercetin treatment reduced the increase of neurological deficit
and infarction, as reported by Park et al. [142] by explaining the respective biochemical
pathways and expressions. Quercetin has shown anti-hypoxic-ischemic injury (HI) in
neonatal mice following the IKK-β/NF-κB pathway, as reported by Jing et al. [143]. Thus,
supporting quercetin as a significant neuroprotective role in preventing brain injury. In
an experimental study, administration of quercetin with different doses in 30 male Wistar
rats was carried out wherein it was suggested that quercetin could be an alternative for
the treatment of spinal cord injury [144]. Kumar et al. [145] reported improved neuronal
survival after exposure to HgCl2 using quercetin and caffeine in hippocampal neurons.
The term ‘disease-modifying drugs’ was referred to as these phytochemicals as these can
serve as future drugs for neurological disorders (e.g., Alzheimer’s disease). The alcoholic
and hexane extract of pumpkin flowers (Cucurbita maxima Duchesne ex Poir) were investi-
gated for neuroprotective potential. The chromatographic results revealed that quercetin
was found in high concentrations. The cholinesterases (acetylcholinesterase and butyryl-
cholinesterase), monoamine oxidase (MAO), and Na+/K+ ATPase activities were carried
out to establish the neuroprotective activity of extracts [146].
Various phytochemicals, including quercetin derivative, were isolated from natural
tea Armeniaca sibirica L., and their neuroprotection role was studied by Zhang et al. [147].
They hypothesized that Armeniaca sibirica L. has promising potential use in the food in-
dustry and addresses neuroprotective issues. Diabetes is associated with brain damage in
mice as stated by Zhu et al. [148] the use of quercetin at high doses increased the levels of
reduced glutathione and activity of superoxide dismutase and thus decreased the levels
of advanced glycation end-products. The improvement in diabetic encephalopathy using
quercetin was established by citing the decrease in protein glycation, oxidative stress, and
inflammation through the upregulation of Glo-1 [148]. Quercetin at the dosage of 50 mg/kg
body weight was reported to help to decrease the symptoms of Alzheimer’s disease [149].
The microscopic analysis revealed that quercetin suppressed H2O2- induced changes in
cell membrane elasticity and morphological properties, leading to the hypothesis of the
neuroprotective role of quercetin [150]. The iron nanoparticles loaded with quercetin were
evaluated for crossing the brain barrier in Wistar rats. After an oral dosage of 100 mg/kg
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body weight of quercetin, the plasma and brain tissue were found to contain a higher
amount of iron nanoparticles as compared to neat quercetin. This availability has suggested
that these loaded nanoparticles can be used as neuroprotective agents [151]. The alcoholic
extract of Colebrookea oppositifolia Smith. was found to be rich in quercetin as detected via
LC-MS results by Viswanatha et al. [152]. The in vivo experiment was carried out in Wistar
rats and found to exhibit a cerebroprotective effect. The inhibition of ROS, nitrite, and
TNF-α in LPS-stimulated RAW 264.7 cell lines has supported its neuroprotective effect. The
reduction of size in quercetin to the nanometric range will increase its bioavailability at the
targeted site, as stated by Ghaffari et al. [153]. The 6-hydroxydopamine (6-OHDA) induced
Parkinson-like model in male rats was studied by them, who reported that treatment
with nanoquercetin prevented the disruption of memory while increasing antioxidant
enzymatic activities such as SOD and catalase decreased the Malondialdehyde (MDA)
level in the hippocampal area of the brain, thus supporting their provided hypothesis
of using quercetin as an anti-Parkinson agent in rats [153]. Similarly, the combination of
quercetin with bio-enhancer piperine has been reported [154] to counter 6-OHDA-induced
Parkinson’s diseases in rats. The quercetin was effective against radiation-induced brain
injury in Wistar rats [155]. The antioxidant and histopathological results revealed that
quercetin is favorable as a neuroprotective agent. The quercetin was found active against
levodopa-induced toxicity in neuroblastoma (SH-SY5Y) cells of olive biophenols, and
based on its enzymatic reaction, it has been hypothesized as a promising natural inhibitor
against the histone deacetylases (HDAC) enzyme by Omar et al. [156]. The traumatic
brain injury (TBI) in rats were treated with quercetin using Neurological Severity Scoring,
immune histochemical, and Western blot analyses. The use of quercetin exhibited signifi-
cant inhibition in extracellular signal-regulated kinase 1/2 phosphorylation and activated
Akt serine/threonine-protein kinase phosphorylation, thus proving its neuroprotective
potential [157]. The pesticide-induced oxidative stress in the brain of rats was treated with
quercetin. The reduction in oxidative stress and increases expression of paraoxanase2
enzyme (PON2) in cultured neural cells led to neuroprotection against oxidative exposure.
Thereby, it proved its role as a neuroprotective agent [158]. Quercetin and biapigenin
into poly (E-caprolactone) (PCL) nanoparticles were studied for their neuroprotective be-
havior by Oliveira et al. [159]. The focal cerebral ischemia was induced in male Sprague
Dawley rats, and after treatment with quercetin neurological function test, brain edema
measurement, and 2,3,5-triphenyl tetrazolium chloride staining were carried out to estab-
lish its effectiveness as a neuroprotective agent. It was hypothesized that quercetin was
successful in preventing the middle cerebral artery occlusion induced activation of apop-
totic pathways affecting caspase-3 and poly ADP-ribose polymerase expression, thereby
establishes its neuroprotective candidature [160]. Quercetin has been found extremely ben-
eficial for nerve regeneration in the Sprague Dawley rat model of sciatic nerve crush injury
using histopathological, morphometric, and biochemical methods as reported by Türedi
et al. [161]. Domoic acid (DA), a well-known neurotoxic agent, damages the hippocampal
area in the brain. Wang et al. [162] studied the effect of quercetin on DA-induced neuro-
toxicity in mice. To their findings, a reduction in mitochondrial dysfunction via increase
of AMPK activity, coupled with an increase in Nrf2 pathway mediated oxidative defense
has been cited as a probable reason to hypothesize quercetin as a neuroprotective agent.
Traumatic brain injury (TBI) and the potential role of the PGC-1α pathway neuroprotection
using quercetin were studied in Wild-type mice by Li et al. [163]. Quercetin treatment
can reduce brain injury in TBI model mice by increasing the activities of mitochondrial
biogenesis through the mediation of the PGC-1α pathway. The neuroprotective behavior
of quercetin in rats can be attributed to the inducing effects on the expression levels of the
brain-derived neurotrophic factor mRNA [164].
The membrane permeability is a concerning issue while delivering quercetin at the in-
jured brain site during ‘Cerebral ischemia–reperfusion’, which results due to the generation
of reactive oxygen species. Thus, quercetin was loaded on polymeric nanocapsules and
directed towards mitochondria and was able to higher brain uptake, thereby controlling
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both generations of ROS as well as the specific delivery of quercetin in the brain [165]. The
effect of quercetin on hippocampal neurons after H2O2 and Aβ-induced neurotoxicity was
treated with quercetin. It was hypothesized by Godoy et al. [166] that quercetin can be
considered as extraordinary means for justifying and explaining molecular mechanisms
associated with Aβ neurotoxicity. The extract from Bougainvillea glabra Choisy leaves
extract rich in quercetin was considered effective in preventing neurological disorders.
The study was supported based on the results of improved locomotor performance and
decreased AChE activity, ROS production, and lipid peroxidation [167]. Similarly, extracts
from Bacopa monnieri were found active against induced oxidative damage in neuroblas-
toma IMR32 cells. The extract was found to contain quercetin and other phytochemicals;
however, the individual role of phytochemicals was not elaborated [168]. The vegetable
extracts of Vernonia amygdalina Delile and Struchium sparganophora L. Kuntze. were found
to show neuroprotective properties. This activity was attributed to stimulation of Na+/K+
ATPase activity, inhibition of 5′-nucleotidase, acetylcholinesterase, butyrylcholinesterase,
and monoamine oxidase activities, as well as Fe2+, induced oxidative stress [169]. Quercetin
was found active against D-galactose-induced neurotoxicity in mice, as reported by Dong
et al. [170]. The presented results stated that quercetin was able to prevent changes in the
neuronal cell morphology with Nrf2, HO-1, and SOD expression along with hippocampus.
In vitro studies reported by Aluani et al. [171], chitosan-based quercetin nanoparticles
exhibited neuroprotective activity. The quercetin in zein nanoparticles was observed to
be a potential candidate for oral treatment of Alzheimer’s disease [172]. Gupta et al. [173]
evaluated the protective effect of quercetin in cadmium-induced cognitive deficits in rats.
They hypothesized that cadmium-induced neurotoxicity could be modulated by quercetin
via molecular targets involved in brain cholinergic signaling. The continuous treatment
of quercetin for 30 days in mice improved the learning and memory loss induced by
amyloid β (Aβ)-peptide exposure. Thus, it was hypothesized that quercetin could be
used as a treatment of neurological disorders [174]. Alzheimer’s and Parkinson’s disease,
both neurological disorders, were hypothesized to be treated by extracts of edible plants
Veronica teucrium L. and Veronica jacquinii Baumg methanol extracts containing quercetin
and its derivatives as reported by Živković et al. [175]. The reduction in enzymes such as
acetylcholinesterase (AChE) and tyrosinase (TYR) concentration after extract treatment led
to such a hypothesis. Quercetin has been found in sea buckthorn (Hippophae rhamnoides L.)
leaves, along with other phytochemicals. The ethyl acetate fraction containing these phy-
tochemicals has been found active and increased the viability and membrane integrity of
neuronal PC-12 cells [176]. Quercetin was found to increase the cell viability in PC-12 cells,
along with a reduction in lactate dehydrogenase (LDH) after exposure to hydrogen perox-
ide, further reducing the apoptosis of PC-12 cells and hippocampal neurons were reported
by Bao et al. [177] thus hypothesizing its role as new potential anti-neurodegenerative
agent, particularly towards the neurodegeneration due to oxidative stress. An in vivo study
in rats for 1-Methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity by
quercetin in combination with piperine at different doses was studied by Singh et al. [178].
The reported results revealed that this combination was quite active in terms of antioxidant
and anti-inflammatory properties as the activity of quercetin was further boosted by the
presence of piperine; furthermore, quercetin, along with piperine, showed resilient neu-
roprotective effects once MPTP neurotoxicity was induced in Wistar rats [178]. The ethyl
acetate fractionated alcoholic extract of Allium cepa Lam. containing quercetin was studied
for diabetic neuropathy in Sprague Dawley rats. The significant neuroprotective effect was
observed after 14 days of quercetin administration against streptozotocin-induced diabetic
neuropathy [179]. Alligator weed (Alternanthera philoxeroides (Mart.) Griseb.) extracts were
also found rich in quercetin along with other phytochemicals as reported by Khamphukdee
et al. [180] and their neuroprotective role was also stated by reporting anti-anxiety property
in mice through estrogenic activity. Similarly, Carpobrotus edulis L. extracts containing
quercetin were found to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase
(BuChE), which were able to reduce hydrogen peroxide (H2O2)-induced injury in the
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human dopaminergic cell line SH-SY5Y as reported by Rocha et al. [181]. In a similar study,
flowers of Reynoutria sachalinensis F. (Schmidt.) Nakai. contained quercetin neuroprotective
activity as revealed by Eom et al. [182]. Ay et al. [183], in their detailed study, explained
the role of quercetin and hypothesized that the cell survival signaling axis was activated by
PKD1-Akt using quercetin, which can be a potential candidate for clinical use in treating
PD. Among many phytochemicals obtained from Potentilla parvifolia Fisch. (Rosaceae),
quercetin exhibited better neuroprotective effects as reflected by Western blot and mor-
phology analysis [184]. Vegetables such as cabbage (Brassica oleracea var. capitata L.) and
cucumber (Cucumis sativus L.) were subjected to aqueous extraction, and in vitro enzymatic
activity of acetylcholinesterase, butyryl-cholinesterase, and monoamine oxidase was inhib-
ited. It was hypothesized that these vegetables could be used to treat neurodegeneration
and were stated as probable sources of functional foods and nutraceuticals for the manage-
ment of Alzheimer’s diseases [185]. Gynostemma laxum Wall. Cogn. containing quercetin
has shown neuroprotective activities and was suggested a natural antioxidant supplement,
but Seo et al. [186] have warned further in-depth in vivo investigation. The erythropoietin
levels were studied in traumatic brain injury in a rat model, and its levels were unaltered
by the use of quercetin, thus justifying its neuroprotective role [187]. Quercetin was used
to inhibit acid-sensing ion channels (ASICs), which are associated with neuronal death
during ischemic stroke, epileptic seizure, and nociception, as reported by Mukhopadhyay
et al. [188]. With the help of computational analysis, they were able to prove the inhibitory
effect of quercetin on ASICs and suggested that further in vivo studies are possibly required
to show that quercetin can target ASICs. The crossing of the blood–brain barrier (BBB)
along with rescuing degenerated neurons, acting on Alzheimer’s disease quercetin was
loaded into colloidal formulation symbolled as RMP-7-Lf-QU-LS by Kuo and Tsao [189],
where RMP-7 is a bradykinin analog, lactoferrin (Lf), quercetin (QU), and liposomes (LS).
The results revealed that this colloidal formulation was effective in overcoming BBB to
prevent Aβ-induced neurodegeneration and can be used to manage Alzheimer’s disease
in proposing future clinical applications. Quercetin was used to check the memory im-
pairment and deterioration of the cholinergic system in rats with an acquired or genetic
disorder of having high levels of lipids in the bloodstream. The increased level of AChE
activity in such rats suggested that quercetin can prevent memory impairment and change
lipid metabolism [190]. In a similar study, the restoration of acetylcholinesterase activity,
an increase of redox status, and lipid peroxidation inhibition in the brain of rats were
controlled by the use of quercetin in manganese-induced neurotoxicity [191]. The quercetin
and its metabolite quercetin-3-O-glucuronide were able to control neural stem cell via-
bility as reported by Baral et al. [192] during an in vivo and in vitro study via contrary
regulation of protein kinase B (Akt). They presented results wherein it was revealed that
the reported mechanism suggests quercetin metabolite to possess therapeutic potential
in treating neurodegenerative ailments. Quercetin was found effective against sodium
fluoride-induced neurotoxicity in rats, as confirmed by Mesram et al. by evaluating bio-
chemical, behavioral, and histopathological parameters [193]. Mehta et al. [194] found
quercetin effective in improving memory dysfunction and rescued neurons from chronic
unpredicted stress-mediated damage. The molecular mechanism of quercetin showing
anticonvulsive behavior was studied in a mouse model by Moghbelinejad et al. [195].
The results revealed that GABAA α5 receptor, which controls the inhibitory signaling in
the central nervous system, was probably responsible for this anticonvulsive behavior of
quercetin, and a further mode of action was warned for further in-depth studies. Salicornia
herbacea L. extracts possessing quercetin were found to provide a neuroprotective effect
via regulating the expression of antioxidant proteins (Nrf2) facilitated introduction of
antioxidant enzymes [196]. The quercetin-protected hippocampal CA1 pyramidal neurons
from ischemic injury was studied by Chen et al. [197], who established their role in provid-
ing resilient neuroprotective effects against transient cerebral ischemia by increasing the
expression of antioxidant enzymes. Quercetin, in combination with donepezil, enhances
cognitive memory in rats by reducing AchE, β amyloid1-42 level in the rat brain [198]. The
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quercetin was able to protect neuronal damage in the retina of diabetic rats by improving
BDNF, NGF, TrkB, synaptophysin, Akt, Bcl-2, cytochrome c, and caspase-3 expression using
Western blotting techniques [199]. The Wistar rats were given quercetin supplementation
for evaluating neuroprotective effects such as a decrease in neuronal and glial body areas
along with a reduction in neuronal and glial density [200]. Quercetin and its nanocrystal
at different concentrations were given orally to rats and increased behavioral indexes
along with the anticipation of anxiogenic-like behavior in them [201]. Eggplant (Solanum
melongena L.) extract containing quercetin was evaluated for its neuroprotective activity
against 6-hydroxydopamine induced in the Parkinsonian rat model [202]. Based on these
reports, quercetin used for neuroprotective use has been tremendously covered. The main
mechanism is either focus on enzymatic reaction, animal models, and dose dependency.
These studies can infer the strongest use of quercetin as a future drug for neurogenerative
diseases. The source of quercetin is of utter importance, although that obtained from
flora, including vegetables and fruits, to support a circular economy, more plant waste,
particularly food waste, should be exploited as a quercetin source. Some recent studies
highlighting the role of quercetin as a neuroprotective agent are depicted in Table 2.
Table 2. Some recent reports on the role of quercetin as a neuroprotective agent.
Role Mode Reference
Antioxidant and AChE inhibitory activity In vitro and in vivo [203]
To prevent the increase in AChE activity in the brain,
improve the memory and anxiety-like behavior In vivo [204]
Proteasome activities In vitro [205]
Against oxidation-induced neuronal necrotic-such as
cell death In vitro [206]
Modulation of neuroinflammation and the
cholinergic system In vivo [207]
Neuronal autophagy and brain injury model by activation
of PI3K/Akt signaling pathway In vivo [208]
Endoplasmic reticulum stress and neuronal cells In vitro [209]
Reduced oxidative/nitrative damage to DNA, lipids, and
proteins of neuroblastoma cell line (SH-SY5Y) cell In vitro [210]
Improves ischemia/reperfusion-induced cognitive
deficits. Inhibition of ASK1/JNK3/caspase-3 Akt
signaling pathway
In vitro [211]
Prevention of brain damage by acrylamide In vivo [212]
Inhibition of µ-calpain protein in hypoxia-induced
neuronal injury In vitro [213]
Autophagy-modulating, Parkinson’s diseases In vivo [214]
Deprivation and restoration of oxygen/glucose, increased
the expression of Nrf2 In vitro [215]
Neuronal death prevention In vivo [216]
Anti-convulsant In vivo [217]
Inhibition of monoamine oxidase (MAO), AChE, and
BChE activities In vitro [218]
Antioxidative insult In vivo [219]
Cerebroprotective action In vivo [220]
Prevention of okadaic-acid-induced injury by MAPK and
PI3K/Akt/GSK3β signaling pathways In vitro [221]
Reduction of oxaliplatin-induced oxidative stress in brain In vitro and in vivo [222]
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Table 2. Cont.
Role Mode Reference
Reduction of immunoreactivity of degenerating neurons In vivo [223]
Parkinson’s disease In vivo [224]
Apoptosis on neural cells via PI3K/Akt signal pathway In vitro [225]
Cerebrovascular disorders In vivo [226]
Alzheimer’s disease (AD) prevention In vivo [227]
Defense of oxidative Stress via PKC- ε
inactivation/ERK1/2 activation In vivo [228]
Neuropathic pain reliever In vitro [229]
Inhibiting oxidative stress and inflammation in
brain injury In vivo [230]
Hypoxic–ischemic brain injury In vivo [231]
Alzheimer’s disease prevention In vitro [232]
Anti-neuroinflammatory In vitro [233]
Enhanced neuronal mitochondrial performance In vitro [234]
Brain therapy, hypoxia In vivo [235]
Anti-inflammatory, antioxidant, and
anti-acetylcholinesterase activities in In vitro [236]
Reduction in oxidative-stress-mediated
neurodegeneration In vivo [237]
Prevention of Parkinson’s disease by gene expression In vitro [238]
Anti-brain ischemic/reperfusion injury using
Akt pathway In vivo [239]
In neuron survival In vitro [240]
Cognitive function In vivo [241]
Antioxidative stress, neuronal damage, In vivo [242]
Protection of human brain cells In vitro [243]
Spatial memory dysfunctions improvement In vivo [244]
Protection of cognitive and emotional functions In vivo [245]
Reduction of cell apoptosis of oxidant-stressed
neuroblastoma (SK-N-MC) cells In vitro [246]
Protects the weakening of memory and
anxiogenic behavior In vitro [247]
Locomotor activities, neurotransmission In vivo [248]
Spinal cord injury treatment In vitro [249]
Perinatal cerebral hypoxia–ischemia In vivo [250]
Protection from oxidative stress and brain edema In vivo [251]
Brain protection In vivo and in vitro [252]
Retinal neuroprotection In vivo [253]
Brain injury treatment In vivo [254]
Neurolemmocytes damage prevention In vivo [255]
Protection of PC12 neural cells In vitro [256]
Multiple therapeutic molecular targets of
Alzheimer diseases In vitro [257]
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Role Mode Reference
Reduction of neuroinflammatory response, antidepressant In vivo [258]
Prevention of hippocampal nerve damage, improved
memory function In vivo [259]
Neuron density In vivo [260]
Prevention of chemical hypoxia In vitro [261]
Inhibition of glutamate release In vitro [262]
Anxiolytic effects In vivo [263]
Ectoenzymes and acetylcholinesterase activities In vivo [264]
Increases levels of mitochondrial enzyme (PON2) in
brain cells In vivo [265]
Nerve protection via Nrf-2/HO-1 activation and
NF-κB inhibition In vivo [266]
Catalepsy normalization, improvement of
neurochemical parameters In vivo [267]
Suppression of cellular acetylcholinesterase (AChE),
protection against oxidative stress In vitro [268]
Preventive medicine for polychlorinated biphenyls
(PCBs)-induced neurotoxicity In vivo [269]
Cerebral ischemia–reperfusion injury treatment In vivo [270]
Protection against induced neurobehavioral impairments In vivo [271]
Neuroprotection in mitochondrial neurotoxin-induced
Parkinson diseases In vivo [272]
Neurovascular coupling protection, decrease in
neurovascular oxidation In vivo [273]
Neuronal protection In vivo [274]
Neuroprotection against brain oxidative stress In vivo [275]
Against neuron death In vivo [276]
Against neurotoxic venoms In vitro [277]
Neurodegeneration protection via production of
ROS scavenging In vivo [278]
Neuroprotection in ypoxic–ischemic brain injury In vivo [279]
Neuroprotection in duodenum enteric nervous system In vivo [280]
Alcoholic neuropathy protection In vivo [281]
Protection in cerebral ischemia through activation of
BDNF-TrkB-PI3K/Akt signaling pathway In vivo [282]
Prevention of oxidative stress in brain In vivo [283]
Reversal of hypobaric hypoxia, neuroprotective
response stimulant In vivo [284]
Diabetic neuropathy prevention In vivo [285]
Prevention of oxidative damage by induced neurotoxicity In vitro [286]
Prevention of cerebral ischemia-induced oxidative stress In vivo [287]
Neuroinflammation prevention In vitro [288]
Cerebral ischemia protection In vitro [289]
Protection Oxidative injury P19 neurons In vitro [290]
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Table 2. Cont.
Role Mode Reference
Lutamate-induced neurotoxicity protection in HT22 cells In vitro [291]
Neuron cell protection In vitro [292]
Oxidative stress In vivo [293]
Decreases the neuronal damage and scavenged free
radicals In vivo [294]
Protection for cerebral ischemic conditions In vivo [295]
Neurodegeneration protection In vivo [296]
3. Quercetin from Food Industry Wastes and By-Products
Food industries, mainly post-fruits and vegetable processing, generate a massive
amount of waste/byproducts, which are usually discarded as landfilling or are subjected
to composting and incineration, which remains a common process of waste disposal.
Managing this type of waste/byproduct is vital, especially to reduce environmental pol-
lution. However, it is worth noting that this cheap source of raw material occurring as
waste/byproducts can be a worthy source of bioactive compounds such as quercetin,
exhibiting rich bioactivities. These bioactives obtained have been explored for their an-
tioxidant, anti-microbial, anti-tumor activities, as well as have been recommended to be
used as a natural coloring and a preservative agent in different industries (such as in
pharmaceuticals, cosmetics, and food industries). Though a wide range of compounds has
been obtained, in the present context, our focus remains on quercetin obtained from vegetal
wastes. Quercetin has been obtained from apple and plum pomace [297–299] as well as
from the peel wastes of banana, kiwi, tomato, and guava fruits [300–303]. Skin wastes of
onion and garlic have been reported as a good source of polyphenolic compounds such as
quercetin, which was shown to exhibit certain bioactivities [304–306]. Besides, quercetin
has been isolated from the peels of different citrus varieties [307]. Polyphenolic compounds
such as gallic, vanillic, syringic, and ferulic acids and p-coumaric derivatives along with
flavonoids such as those of quercetin and its derivatives have been obtained from the
‘lees’ generated post ‘pisco’ production process [308]. Among the fruit seed wastes, grape
seeds are reported to be rich in polyphenols, resveratrol, quercetin, and other flavonoid
compounds, which are confirmed to impart cardiovascular protective effects [309]. In pa-
paya seeds, quercetin and quercetin 3-O-glycoside have been isolated [310]. Furthermore,
seeds of Theobroma grandiflorum (a tree related to cacao) are reported to be a rich source of
bioactive sulfated flavonoid glycosides, quercetin, quercetin 3-O-D-glucuronide, and other
polyphenolic compounds [311]. Quercetin and isoquercetin have been obtained from the
mango seed kernel, too [312].
On another note, among various types of leaves studied, quercetin-3-O-(6”-feruloyl)-β-D-
galactopyranoside was obtained from guava plants leaves (Psidium guajava L.), which demon-
strated rich bioactives [313], while quercetin-3-O-rutinoside, quercetin-3-orobinobioside
and quercetin-3-O-galactoside were isolated from chokeberry leaves [314,315] In the
cranberry leaves (+)-catechin, procyanidin B1, (−)-epicatechin have been isolated [314].
From the quince leaves, quercetin-3-O-galactoside, quercetin-3-O-rutinoside have been
obtained [314,316]. On another note, elderberry (Sambucus nigra L.) branch wastes have
been explored to obtain quercetin and its glycoconjugate derivatives [317]. Residues ob-
tained from broccoli-processing industries (stalks and florets) have been explored to obtain
glucosinolate, polyphenols, and flavonoids such as quercetin [318]. Cauliflower wastes
extracts (stems and leaves) are also reported to contain high amounts of flavonoid glyco-
sides, mainly derived from quercetin and kaempferol [319,320]. Apart from fresh produce
waste, quercetin has been reported in other wastes such as sugarcane (Saccharum officinarum
L.), bagasse [321,322], acerola (Malpighia emarginata DC.), flour bagasse [323], stalks of
Euonymus alatus (Thunb.) Sieb. [324], and peanut shells [325]. With the available informa-
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tion in the scientific databases, it is quite evident that food industrial wastes/byproducts
(mainly those of fruits and vegetables based) hold high scope for obtaining quercetin. The
food waste/byproducts containing quercetin by the amount reported in recent years are
summarized in Table 3.
Table 3. Quercetin in food industrial wastes and byproducts.
Waste/By-Products Quantity (mg/g) * Reference
Tomato peels 9.97 ± 0.27 [326]
Berry peel 0.0001 ± 0.00 [327]
Lotus byproducts (Only detected not quantified) [328]
Coppery onion outer dry layers 52.84 ± 0.12 [329]
Red grape pomace 0.05 ± 0.00 [330]
Cacao beans pod husk 0.6018 ± 0.0112 [331]
Grape pomace 0.03189 ± 0.00277 [332]
Grape pomace 0.24923 ± 0.00114 [333]
Onion waste (A case study of industrial scale,output yield is in Kgs) [334]
Black currant residue with quercetin
glycoside (based on the place of cultivation) 34.6 ± 5.7 [335]
* The units presented are converted to (mg/g) as compared to different units reported in the references.
4. Conclusions
The tremendous effort by researchers to bring attention to the importance of quercetin
as a cardioprotective and neuroprotective agent has led to a new milestone in discovering
it as a potential therapeutical candidate. The sustainable resources from plant sources,
in particular, vegetables, have added value to this research. A paradigm shift is needed
to utilize food waste or food byproducts as a continued sustainable resource of this sec-
ondary metabolite. The main challenge in tabulating quercetin as a cardioprotective and
neuroprotective agent is the diversion of demand from fresh resources to non-utilized
food waste. However, other challenges, such as the specific targeted delivery of quercetin
and its understanding of the cellular metabolism of quercetin derivatives, need a more
interdisciplinary approach. The use of nano-particulate quercetin can be carried out in
the future based on the sources of origin, which in turn can increase the bioavailability
of quercetin at the drug-targeted site for cardiovascular and neurological diseases. The
cellular mechanism, targeted delivery, and above all effectiveness, of quercetin in treating
cardioprotective and neuroprotective diseases has been remarkably covered by researchers;
however, the quercetin sources from fresh fruits and vegetables and synthetic methods
are needed to be diverted to food wastes or byproducts. Further research is also required
to identify the purity of quercetin, its safety efficacy, and meet the standard regulations
of governing bodies (e.g., EU legislation). Thus, this review warrants further extensive
research activities to be undertaken to obtain quercetin from underexplored plant produce
(e.g., vegetables and fruits) as well as food-industry processing wastes and byproducts,
mainly originating from fruits and vegetables.
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155. Kale, A.; Pişkin, O.; Baş, Y.; Aydln, B.G.; Can, M.; Elmas, Ö.; Büyükuysal, Ç. Neuroprotective effects of quercetin on radiation-
induced brain injury in rats. J. Radiat. Res. 2018, 59, 404–410. [CrossRef] [PubMed]
156. Omar, S.H.; Scott, C.J.; Hamlin, A.S.; Obied, H.K. Biophenols: Enzymes (β-secretase, Cholinesterases, histone deacetylase and
tyrosinase) inhibitors from olive (Olea europaea L.). Fitoterapia 2018, 128, 118–129. [CrossRef]
157. Du, G.; Zhao, Z.; Chen, Y.; Li, Z.; Tian, Y.; Liu, Z.; Liu, B.; Song, J. Quercetin protects rat cortical neurons against traumatic brain
injury. Mol. Med. Rep. 2018, 17, 7859–7865. [CrossRef]
158. Ghahremani, S.; Soodi, M.; Atashi, A. quercetin ameliorates chlorpyrifos-induced oxidative stress in the rat brain: Possible
involvment of PON2 pathway. J. Food Biochem. 2018, 42, 3. [CrossRef]
159. Oliveira, A.I.; Pinho, C.; Fonte, P.; Sarmento, B.; Dias, A.C.P. Development, characterization, antioxidant and hepatoprotective
properties of poly(E-caprolactone) nanoparticles loaded with a neuroprotective fraction of Hypericum perforatum. Int. J. Biol.
Macromol. 2018, 110, 185–196. [CrossRef] [PubMed]
160. Park, D.-J.; Shah, F.-A.; Koh, P.-O. Quercetin attenuates neuronal cells damage in a middle cerebral artery occlusion animal model.
J. Vet. Med. Sci. 2018, 80, 676–683. [CrossRef] [PubMed]
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